Skip to content

Glucocorticoid replacement therapy and fibrinolysis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN93511659
Enrollment
25
Registered
2005-09-30
Start date
2004-11-19
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine: Hypopituitarism Nutritional, Metabolic, Endocrine Hypopituitarism

Interventions

The study will be of randomised, open-label, crossover design, comparing the effects of traditional glucocorticoid replacement regimens versus modern regimens on fibrinolytic parameters in patients wi

Sponsors

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients over 18 years with documented adult hypopituitarism with proven ACTH deficiency, currently under follow up in the Bradford Teaching Hospitals NHS Trust, who have provided informed consent will be potentially eligible to participate in the study. Patients will be recruited from either direct contact in OPD or via direct phone contact with an endocrine specialist nurse.

Exclusion criteria

Exclusion criteria: 1. Subjects requiring systematic steroid therapy 2. Subjects taking HRT or oral contraceptive 3. Subjects who are currently pregnant or who had recent pregnancy or abortion 4. Subjects with known malignancy 5. Subjects with known coagulopathy 6. Subjects who are currently taking or have recently taken anticoagulant therapy

Design outcomes

Primary

MeasureTime frame
Fibrinolytic parameter measurements.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026